Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best low priced pharma stocks to buy now. On July 13, Amylyx ...

A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program designed to facilitate the kind of precision genome editing involved in the ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

This innovative software, CRISPRware, optimizes guide RNA design for genome editing, supporting research on genetic disorders ...

Jenny Mollen, the US TV star was rushed to the ER after a severe reaction to the weight-loss drug tirzepatide. She later revealed emotional side effects, including anxiety, numbness, and loss of joy ...

The Semaglutide peptide has emerged as a compelling subject in biochemical and physiological research due to its potential ...

Because glucagon in animals has positive inotropic and chronotropic effects in the presence of beta-adrenergic blockade, catecholamine depletion or full digitalization, its cardiovascular effects i ...

Terns' late-stage assets target CML & obesity with key data in Q4 2025. Explore their potential in massive markets. Click ...

Lotte Bjerre Knudsen, Chief Scientific Adviser for Research at Danish pharma giant Novo Nordisk, speaks about GLP-1-based ...